Malta vs Oman: Share of S. aureus infections resistant to methicillin
Malta
19.9%
in 2022
Oman
28.6%
in 2022
Malta rank
24th
Oman rank
21st
Share of S. aureus infections resistant to methicillin over time
- Malta
- Oman
How they compare
Oman currently reports 28.6% against 19.9% in Malta, a difference of 8.7%.
That makes Oman's figure about 1.4 times Malta's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Malta ahead.
Malta ranks 24th and Oman ranks 21st of 45 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malta | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 39.8% | 45.5% | 5.7% | Oman |
| 2020s | 19.9% | 33.9% | 14.0% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Malta or Oman?
- Oman, at 28.6% against 19.9% in Malta as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Malta and Oman?
- 8.7%, with Oman ahead.
- How many years of comparable data are there for Malta and Oman?
- 5 years are reported by both, from 2017 to 2022.
- How do Malta and Oman rank globally for share of s. aureus infections resistant to methicillin?
- Malta ranks 24th and Oman ranks 21st of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).